Mednet Logo
HomeRheumatology
Rheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

How do you counsel patients with osteoporosis and cervical spine osteoarthritis who are considering chiropractic cervical manipulation or traction?

1 Answers

Mednet Member
Mednet Member
Rheumatology · University of Kansas

I am concerned with the risks of actually causing a fracture or nerve impingement/damage. So, I would recommend against.

Do you recommend vitamin K2 supplements in patients with osteoporosis?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Icahn School of Medicine at Mount Sinai

The answer, as with most vitamin supplementations, cannot be answered with high-level evidence to support a "yes or no". A bit of background and then a brief review of available evidence.Vitamin K is thought to be important for bone health because it activates several proteins involved in bone forma...

What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?

3
1 Answers

Mednet Member
Mednet Member
Rheumatology · Tidalhealth

A workup to rule out secondary causes must be done prior to starting therapy for osteoporosis. A good history and exam are recommended to look for any clues for modifiable factors. At a minimum, one should do CMP, 25-OH vitamin D, TSH, and a 24-hour urinary calcium or calcium/creatinine ratio should...

Was the methotrexate dose reduced over time in the combination therapy or methotrexate monotherapy groups in the SEAM-RA trial?

1 Answers

Mednet Member
Mednet Member
Rheumatology · University of Alabama

No, methotrexate dose was not adjusted. Our goal was basically to answer one question: whether it is better to stop etanercept, stop methotrexate, or continue both. We did not want to be adjusting methotrexate doses at the same time as stopping because this would make results more difficult to inter...

What was the rationale for abrupt discontinuation of etanercept rather than gradual tapering in the SEAM-RA trial?

2 Answers

Mednet Member
Mednet Member
Rheumatology · University of Alabama

The main goal of this trial was to get RA patients off of therapy and to see whether they would flare or maintain remission. We didn’t expect that the ultimate likelihood of success or failure was going to be primarily related to how long it took to do that. While a gradual withdrawal of the drug ma...

When should bone biopsy be considered to guide management in patients in whom you're differentiating osteoporosis and renal osteodystrophy?

1 Answers

Mednet Member
Mednet Member
Nephrology · Indiana University School of Medicine

This is a major issue in patients with advanced CKD. Definitive RCT treatment trials for osteoporosis had an inclusion criteria of a normal PTH and an exclusion criteria of elevated creatinine greater than 1.1 to 1.5 (depending on the study). Therefore, in patients with CKD 3 and more severe CKD, AN...

Do you recommend allopurinol desensitization in gout patients who develop a rash on allopurinol therapy?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · National institues of Health

I don't recommend desensitization for allopurinol-allergic patients. There was a time when this made sense due to the lack of a viable alternative therapy. The process is cumbersome in a private practice setting and not as simple as providing the patient with a prescription for febuxostat.Febuxostat...

How do you work with patients to establish reasonable treatment goals for the management of fibromyalgia-related pain?

2
2 Answers

Mednet Member
Mednet Member
Rheumatology · Tufts University School of Medicine

It is important that patients understand that fibromyalgia (FM) is a nociplastic (CNS-driven) pain condition, rather than primarily a peripheral musculoskeletal pain disorder. This provides a framework for linking the treatment of pain to that of sleep, fatigue, and mood. Patients then generally acc...

Do you check for JCV before starting belimumab?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

No. The John Cunningham virus (JCV) is highly prevalent in adults (around 85% of us), and developing progressive multifocal leukoencephalopathy (PML) is incredibly rare in belimumab (BEL) patients. It would not change my patient management. Even if someone tested negative for JCV prior to starting ...

Which serologic tests are most helpful when evaluating for suspected drug-induced lupus?

2
2 Answers

Mednet Member
Mednet Member
Dermatology · Stanford University School of Medicine

If I suspect drug-induced lupus, I typically order the following laboratory testing: ANA/IFA Anti-histone antibody, usually positive in drug-induced lupus Anti-Ro antibody, usually positive in drug-induced subacute cutaneous lupus Anti-dsDNA, usually negative in drug-induced lupus vs positive in id...